1 April 2019 - The April 2019 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The April issue of the Schedule includes a number of new/revised listings:

• Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine (PKU Baby) - restriction change
• Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine (PKU Start) - new formulation
  
• Brentuximab vedotin (Adcetris) - new indication
  
• Cerliponase alfa (Brineura) - new medicine (LSDP listing)
• Filgrastim - restriction change
• Riluzole (Tegulek) - new formulation
• Safinamide mesylate (Xadago) - new medicine
• Sofosbuvir with velpatasvir and voxilaprevir (Vosevi) - new combination product

Read summary of changes